Therefore, we evaluated the association between baseline PD-L1 expression and prognosis in patients with ALK-rearranged advanced NSCLC, performed a comprehensive analysis of the TME of patients with a high PD-L1 expression, and analysed the impact of the TME on prognosis. Here, ALK is linked to non-small cell lung carcinoma.